126 related articles for article (PubMed ID: 7417037)
1. The road toward the identification of middle molecules. Preliminary Committee Meeting, Avignon, France November 28-29, 1980.
Bergstrom J; Funck-Brentano JL; Klinkmann H
Artif Organs; 1980 Aug; 4(3):209-10. PubMed ID: 7417037
[No Abstract] [Full Text] [Related]
2. Uremic toxins and the elusive middle molecules.
Schoots A; Mikkers F; Cramers C; de Smet R; Ringoir S
Nephron; 1984; 38(1):1-8. PubMed ID: 6472528
[No Abstract] [Full Text] [Related]
3. Middle molecules in uraemia.
Fürst P; Asaba M; Gordon A; Zimmerman L; Bergström J
Proc Eur Dial Transplant Assoc; 1975; 11():417-26. PubMed ID: 1105558
[No Abstract] [Full Text] [Related]
4. Serum middle molecules in uremia.
Buzio C; Manari A; Calderini C; Montagna G; Migone L
Artif Organs; 1981; 4 Suppl():143-50. PubMed ID: 7295081
[No Abstract] [Full Text] [Related]
5. [Study of toxic activity of blood in uremia].
Shumakov VI; Gabriélian NI; Shcherbaneva OI; Dmitriev AA; Mogireva IA
Ter Arkh; 1980; 52(4):62-4. PubMed ID: 7404340
[No Abstract] [Full Text] [Related]
6. Uremic middle molecules exist and are biologically active.
Bergström J; Fürst P; Zimmerman L
Clin Nephrol; 1979 May; 11(5):229-38. PubMed ID: 455821
[No Abstract] [Full Text] [Related]
7. Investigations on clinico-chemical correlations in uraemic polyneuritis.
Man NK; Cueuille G; Zingraff J; Drueke T; Jungers P; Sausse A; Billon JP; Funck-Brentano JL
Proc Eur Dial Transplant Assoc; 1975; 11():214-21. PubMed ID: 1197256
[No Abstract] [Full Text] [Related]
8. A defense of the middle molecule hypothesis.
Funck-Brentano JL; Cueille GF; Man NK
Kidney Int Suppl; 1978 Jun; (8):S31-5. PubMed ID: 278894
[No Abstract] [Full Text] [Related]
9. [Studies on the significance of middle molecular retention products as uremia toxins].
Goubeaud G; Leber HW; Schott HH
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1244-6. PubMed ID: 611827
[No Abstract] [Full Text] [Related]
10. Preparative isolation of middle molecular weight fractions from the hemofiltrate of patients with chronic uremia.
Brunner H; Mann H; Essers U; Schultheis R; Byrne T; Heintz R
Artif Organs; 1978 Nov; 2(4):375-7. PubMed ID: 743009
[TBL] [Abstract][Full Text] [Related]
11. Removal of high-molecular-weight toxins.
Hörl WH
Contrib Nephrol; 1992; 96():138-44. PubMed ID: 1740048
[No Abstract] [Full Text] [Related]
12. [A comparison of the efficiency of eliminating middle-weight molecules and myoinositol from plasma during hemoperfusion and hemodialysis in cases of chronic uremia].
Trznadel K; Kidawa Z; Walasek L; Lutz W
Pol Tyg Lek; 1978 Feb; 33(7):257-9. PubMed ID: 758030
[No Abstract] [Full Text] [Related]
13. What remains of the "middle molecule" hypothesis today?
Brunner H; Mann H
Contrib Nephrol; 1985; 44():14-39. PubMed ID: 3886282
[No Abstract] [Full Text] [Related]
14. [Hydrophobic uremic middle molecules in hemofiltrate of a dialysis patient].
Konobu K; Matsumoto T; Sawanishi K
Nihon Jinzo Gakkai Shi; 1988 Feb; 30(2):151-60. PubMed ID: 3386019
[No Abstract] [Full Text] [Related]
15. Methodology for identification of serum middle molecules.
Buzio C; Montagna G; Calderini C; Manari A; Migone L
Artif Organs; 1981; 4 Suppl():22-7. PubMed ID: 7295090
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of blood toxicity in chronic uremia by an improved chromatographic method.
Politi L; D'Angelo AR; Caramia M; Molinaro M; Nicoletti R; Cerulli N; Moriggi M; Scandurra R
Clin Exp Dial Apheresis; 1981; 5(3):277-84. PubMed ID: 7333038
[TBL] [Abstract][Full Text] [Related]
17. Toxicity of uremia: physiopathology and clinical signs.
Bergström J
Contrib Nephrol; 1989; 71():1-9. PubMed ID: 2680257
[No Abstract] [Full Text] [Related]
18. [Uremic toxin and dialysis].
Nakagawa S
Nihon Jinzo Gakkai Shi; 1976 Jun; 18(6):430-2. PubMed ID: 988349
[No Abstract] [Full Text] [Related]
19. Inhibition of phagocytosis by a middle molecular fraction from ultrafiltrate.
Ringoir SM; van Landschoot N; de Smet R
Clin Nephrol; 1980 Mar; 13(3):109-12. PubMed ID: 7379359
[TBL] [Abstract][Full Text] [Related]
20. [Effect of chromatographic fractions of blood ultrafiltrates of patients with chronic uremia on the fibrinolytic activity]].
Popławski A; Myśliwiec M; Soszka J
Pol Tyg Lek; 1990 Oct 1-8; 45(40-41):810-3. PubMed ID: 2096374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
